Paloma Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-952
| Closed | -$314K | – | 1733 |
|
|
2024
Q2 | $314K | Buy |
+952
| New | +$336K | 0.01% | 897 |
|
|
2022
Q3 | – | Sell |
-2,650
| Closed | -$801K | – | 1380 |
|
|
2022
Q2 | $801K | Buy |
+2,650
| New | +$862K | 0.03% | 495 |
|
|
2021
Q3 | – | Sell |
-4,361
| Closed | -$1.57M | – | 1960 |
|
|
2021
Q2 | $1.57M | Buy |
4,361
+1,920
| +79% | +$634K | 0.03% | 480 |
|
|
2021
Q1 | $688K | Sell |
2,441
-6,526
| -73% | -$1.87M | 0.01% | 911 |
|
|
2020
Q4 | $2.54M | Buy |
8,967
+409
| +5% | +$115K | 0.07% | 306 |
|
|
2020
Q3 | $2.35M | Sell |
8,558
-3,130
| -27% | -$828K | 0.06% | 344 |
|
|
2020
Q2 | $2.65M | Buy |
11,688
+8,956
| +328% | +$1.76M | 0.05% | 511 |
|
|
2020
Q1 | $415K | Sell |
2,732
-764
| -22% | -$118K | 0.02% | 569 |
|
|
2019
Q4 | $526K | Sell |
3,496
-17,530
| -83% | -$2.55M | 0.01% | 1373 |
|
|
2019
Q3 | $2.98M | Buy |
21,026
+4,678
| +29% | +$644K | 0.06% | 268 |
|
|
2019
Q2 | $2.05M | Buy |
16,348
+14,367
| +725% | +$1.7M | 0.03% | 408 |
|
|
2019
Q1 | $218K | Buy |
+1,981
| New | +$206K | 0.01% | 1474 |
|
|
2018
Q4 | – | Sell |
-7,300
| Closed | -$901K | – | 1828 |
|
|
2018
Q3 | $901K | Buy |
7,300
+2,152
| +42% | +$241K | 0.02% | 790 |
|
|
2018
Q2 | $511K | Sell |
5,148
-14,535
| -74% | -$1.34M | 0.01% | 1027 |
|
|
2018
Q1 | $1.74M | Buy |
19,683
+15,259
| +345% | +$1.43M | 0.03% | 662 |
|
|
2017
Q4 | $437K | Buy |
4,424
+659
| +18% | +$64.6K | 0.01% | 1386 |
|
|
2017
Q3 | $362K | Sell |
3,765
-9,807
| -72% | -$887K | 0.01% | 1710 |
|
|
2017
Q2 | $1.28M | Buy |
13,572
+219
| +2% | +$20.1K | 0.02% | 1051 |
|
|
2017
Q1 | $1.09M | Buy |
+13,353
| New | +$1.12M | 0.01% | 1189 |
|
|
2016
Q4 | – | Sell |
-12,714
| Closed | -$947K | – | 2173 |
|
|
2016
Q3 | $947K | Sell |
12,714
-114,846
| -90% | -$9.12M | 0.01% | 1060 |
|
|
2016
Q2 | $9.68M | Buy |
+127,560
| New | +$9.28M | 0.11% | 107 |
|
|
2016
Q1 | – | Sell |
-5,388
| Closed | -$325K | – | 2097 |
|
|
2015
Q4 | $325K | Sell |
5,388
-7,387
| -58% | -$444K | 0.01% | 1282 |
|
|
2015
Q3 | $691K | Buy |
12,775
+7,475
| +141% | +$436K | 0.02% | 853 |
|
|
2015
Q2 | $308K | Sell |
5,300
-1,860
| -26% | -$104K | 0.01% | 1317 |
|
|
2015
Q1 | $431K | Buy |
+7,160
| New | +$382K | 0.01% | 842 |
|
|
2014
Q3 | – | Sell |
-23,238
| Closed | -$980K | – | 1324 |
|
|
2014
Q2 | $980K | Buy |
23,238
+112
| +0.5% | +$4.8K | 0.04% | 345 |
|
|
2014
Q1 | $1.02M | Sell |
23,126
-76,914
| -77% | -$3.62M | 0.07% | 234 |
|
|
2013
Q4 | $4.91M | Buy |
+100,040
| New | +$4.68M | 0.25% | 95 |
|
|
2013
Q3 | – | Sell |
-6,006
| Closed | -$211K | – | 1214 |
|
|
2013
Q2 | $211K | Buy |
+6,006
| New | +$198K | 0.01% | 840 |
|
Other funds holding WST
Paloma Partners's WST Position: Q3 2024 in Review
Paloma Partners sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 952 shares — an estimated $314K sold.
Paloma Partners first reported a position in WST in Q2 2013 and held it in 29 quarters. The position peaked at $9.68M in Q2 2016. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.
- Paloma Partners reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 952 West Pharmaceutical shares in Q3 2024, an estimated $314K.
- Paloma Partners first reported a position in West Pharmaceutical in Q2 2013 and held it in 29 quarters.
- Paloma Partners's West Pharmaceutical position peaked at $9.68M in Q2 2016.
- 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.